Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Mototsugu, Nagao"'
Autor:
Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, Ichiro Sakuma, Hitoshi Sugihara, Shinichi Oikawa, on behalf of the SUCRE Study Investigators
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background SGLT2 inhibitors and DPP4 inhibitors have been suggested to affect lipid metabolism. However, there are few randomized controlled trials comparing the effects on the lipid metabolism between the two types of antidiabetic drugs. Th
Externí odkaz:
https://doaj.org/article/d107cb69317a496eb44d1dc59de64855
Autor:
Hiroki Ono, Masanori Atsukawa, Akihito Tsubota, Taeang Arai, Kenta Suzuki, Tetsuyuki Higashi, Michika Kitamura, Kaori Shioda‐Koyano, Tadamichi Kawano, Yuji Yoshida, Tomomi Okubo, Korenobu Hayama, Norio Itokawa, Chisa Kondo, Mototsugu Nagao, Masato Iwabu, Katsuhiko Iwakiri
Publikováno v:
JGH Open, Vol 8, Iss 4, Pp n/a-n/a (2024)
Abstract Background and Aim This study aimed to clarify the efficacy and safety of 48‐week pemafibrate treatment in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) complicated by dyslipidemia. Methods A total of 110
Externí odkaz:
https://doaj.org/article/cd543728d12b41028b02332794275195
Autor:
Noriyuki Nishiwaki, Yoshihiro Mikuriya, Fumiaki Takatsu, Ryoji Ochiai, Tomokazu Kakishita, Naruyuki Kobayashi, Takaya Kobatake, Shinji Hato, Norihiro Teramoto, Mototsugu Nagao, Izumi Fukuda, Koji Ohta
Publikováno v:
Surgical Case Reports, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract Background Tumor-produced high molecular weight insulin-like growth factor-II (big insulin-like growth factor-II) is considered to cause non-islet cell tumor hypoglycemia. This paper presents a case of surgically resected retroperitoneal lip
Externí odkaz:
https://doaj.org/article/40db2401462546aca3915da0fc7a99c4
Autor:
Mototsugu Nagao, Taro Harada, Kyoko Tanimura-Inagaki, Shunsuke Kobayashi, Izumi Fukuda, Hitoshi Sugihara, Shinichi Oikawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract There is no standard formula for estimating the starting daily dose (SDD) of basal-bolus insulin therapy (BBT). We aimed to develop a formula for estimating SDD and evaluate its efficacy and safety in patients with type 2 diabetes hospitaliz
Externí odkaz:
https://doaj.org/article/3f46b09495164a4aae244ce07108722d
Autor:
Mototsugu Nagao, Jun Sasaki, Hitoshi Sugihara, Kyoko Tanimura-Inagaki, Taro Harada, Ichiro Sakuma, Shinichi Oikawa, STREAM Study Investigators
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Sitagliptin has been suggested as a treatment option for older adults with type 2 diabetes (T2D). However, no randomized controlled trial has been performed to evaluate the efficacy and safety of sitagliptin treatment in older Japanese patie
Externí odkaz:
https://doaj.org/article/c0603767dc4047c592aabd1280f0e133
Autor:
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Shigeru Mikami, Uojima Haruki, Keiichiro Yoshikata, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Korenobu Hayama, Ai Nakagawa‐Iwashita, Norio Itokawa, Chisa Kondo, Keiko Kaneko, Mototsugu Nagao, Kyoko Inagaki, Izumi Fukuda, Hitoshi Sugihara, Katsuhiko Iwakiri
Publikováno v:
Hepatology Communications, Vol 6, Iss 11, Pp 3073-3082 (2022)
Abstract The aim of this retrospective multicenter study was to clarify the antifibrotic effect and long‐term outcome of sodium glucose cotransporter 2 inhibitors (SGLT2‐Is) in patients with nonalcoholic fatty liver disease (NAFLD) complicated by
Externí odkaz:
https://doaj.org/article/a0a0f71eaf584c6ead3f7964f2a90c32
Autor:
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Hirotaka Ono, Tadamichi Kawano, Yuji Yoshida, Tomomi Okubo, Korenobu Hayama, Ai Nakagawa‐Iwashita, Norio Itokawa, Chisa Kondo, Mototsugu Nagao, Katsuhiko Iwakiri
Publikováno v:
JGH Open, Vol 6, Iss 7, Pp 503-511 (2022)
Abstract Background and Aim This study aimed to clarify the efficacy and safety of oral semaglutide treatment in patients with non‐alcoholic fatty liver disease (NAFLD) complicated by type 2 diabetes mellitus (T2DM). Methods This was a single‐arm
Externí odkaz:
https://doaj.org/article/9479698875784436a9808b3b5dfce8ee
Autor:
Yamato Keidai, Takaaki Murakami, Nana Yamamura, Shigeru Tsunoda, Atsushi Ikeda, Koya Hida, Mototsugu Nagao, Yosuke Yamada, Ayaka Fukui, Masahito Ogura, Izumi Fukuda, Yuji Nakamoto, Kazutaka Obama, Nobuya Inagaki
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundNon-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome caused by a tumor-producing high molecular weight form of insulin-like growth factor 2 (IGF2) known as big IGF2. The only curative treatment for this condition is s
Externí odkaz:
https://doaj.org/article/1a8f6d28b75f4114a9208798072f6ab4
Autor:
Mikiko Okazaki-Hada, Izumi Fukuda, Ryuta Nagaoka, Mototsugu Nagao, Takehito Igarashi, Shunsuke Kobayashi, Takeshi Oba, Yuji Yamaguchi, Tomoko Nagamine, Iwao Sugitani, Hitoshi Sugihara
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 13 (2022)
Pheochromocytomas can present with various symptoms. Nonspecific manifestations of pheochromocytoma include intestinal pseudo-obstruction and weight loss. Here, we present a case of pheochromocytoma in which prolonged intestinal pseudo-obstruction du
Externí odkaz:
https://doaj.org/article/5ee0bff5e9ae43018acc83bd7c20309b
Autor:
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Keizo Kato, Hiroshi Abe, Hirotaka Ono, Tadamichi Kawano, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Korenobu Hayama, Ai Nakagawa-Iwashita, Norio Itokawa, Chisa Kondo, Keiko Kaneko, Naoya Emoto, Mototsugu Nagao, Kyoko Inagaki, Izumi Fukuda, Hitoshi Sugihara, Katsuhiko Iwakiri
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Nonalcoholic fatty liver disease (NAFLD) is related to subclinical atherosclerosis. However, whether the severity of the disease (or which histopathological component) is associated with subclinical atherosclerosis remains controversial. Thi
Externí odkaz:
https://doaj.org/article/cce14aab56cd4efc9e98f6b71059a6f9